RWIN - ETF AI Analysis
Top Page
Rayliant NxtGen Multifactor International Equity ETF (RWIN)
RWIN, the Rayliant NxtGen Multifactor International Equity ETF, earns a solid overall rating driven mainly by strong, diversified holdings like ASML, Suncor Energy, and Power Corp of Canada, which show robust financial performance, good earnings growth, and generally supportive technical trends. Some positions, such as Allianz and stocks with bearish or overbought technical signals, slightly weigh on the rating and highlight short-term volatility risks. The main risk factor is exposure to individual names with expensive valuations or weak momentum, which can increase sensitivity to market swings even within a diversified international portfolio.
RWIN vs. SPDR S&P 500 ETF (SPY)
- AUM
- 20.39M
- Region
- Developed Markets
- Expense Ratio
- 0.42%
- Beta
- 0.48
- Issuer
- Rayliant
- Inception Date
- Apr 07, 2026
- Dividend Yield
- 1.17%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
RWIN Summary
RWIN, the Rayliant NxtGen Multifactor International Equity ETF, is an actively managed fund that invests in stocks from developed countries outside the U.S., such as Japan, the UK, and Germany. It doesn’t track a single index, but follows a “multifactor” theme that aims to favor higher-quality companies of all sizes. Well-known holdings include Roche and ASML. Investors might consider RWIN to diversify beyond U.S. stocks while spreading money across many sectors and countries. A key risk is that international stock prices can be volatile and may rise or fall with global markets and currency movements.
How much will it cost me?
This ETF has an expense ratio of 0.42%, which means you’ll pay about $4.20 per year for every $1,000 you invest. That’s higher than the cost of a typical low-cost index ETF because this fund is actively and quantitatively managed, aiming to add value by carefully selecting and weighting international stocks.
What would affect this ETF?
RWIN could benefit if developed markets outside the U.S. grow steadily, especially if financials, health care, and technology companies like Roche, ASML, and major insurers continue to perform well and global interest rates stabilize or fall, supporting stock prices. On the other hand, slower economic growth abroad, rising interest rates that pressure financial firms, or new regulations affecting big international companies could hurt returns, and the fund’s active, multifactor approach may lag simple market indexes in certain market environments.
RWIN Top 10 Holdings
RWIN’s story is driven by a mix of global heavyweights, with a clear tilt toward non-U.S. financials, health care, and industrials. European names like Roche are steadily lifting the fund, while energy players Suncor and Repsol have been rising and giving performance an extra push. On the tech side, ASML and Advantest have been strong over the year, even if ASML’s recent stretch looks a bit mixed. Large insurers such as AXA, Allianz, and Japan’s MS&AD are more of a slow-and-steady crew, occasionally lagging but anchoring this diversified developed-markets ex-U.S. lineup.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 SU | Suncor Energy | ― | ― | ― | ― | 77Outperform |
 FR:CS | AXA SA | 2.11% | $432.59K | EUR 87.97B | 8.92% | 75Outperform |
 NL:ASML | ASML Holding NV | 2.19% | $448.52K | EUR 574.81B | 63.67% | 76Outperform |
 DE:ALV | Allianz | 2.10% | $430.37K | EUR 166.47B | 24.08% | 67Neutral |
 MSADF | MS&AD Insurance Group Holdings | ― | ― | ― | ― | 69Neutral |
 JP:8750 | Dai-ichi Life Holdings | 1.72% | $353.16K | JPY 6.55T | 69.57% | 69Neutral |
 JP:6857 | Advantest | 1.87% | $384.21K | JPY 25.83T | 67.41% | 75Outperform |
 ES:REP | Repsol | 1.57% | $321.09K | EUR 31.73B | 84.85% | 72Outperform |
 TSE:POW | Power Corp of Canada | 1.62% | $332.19K | CAD 61.09B | 52.30% | 76Outperform |
RWIN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RWIN, the sentiment is Positive. The current price of 27.47 is above the 20-day moving average (MA) of 26.95, above the 50-day MA of 27.25, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 60.50 is Neutral, neither overbought nor oversold. The STOCH value of 82.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RWIN.
RWIN Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RWIN | $27.47 | $29.00(5.56% Upside) | $20.39M | 0.42% | 66Neutral |
 INEQ | $39.41 | $47.16(19.67% Upside) | $92.08M | 0.45% | 66Neutral |
 LCIV | $25.93 | ― | $20.14M | 0.99% | 67Neutral |
 FFDI | $31.12 | $38.62(24.12% Upside) | $18.53M | 0.55% | 67Neutral |
 JINT | $25.16 | $34.47(37.01% Upside) | $9.99M | 0.35% | 67Neutral |
 PRXI | $25.07 | $30.20(20.45% Upside) | $6.79M | 0.54% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RWIN | Rayliant NxtGen Multifactor International Equity ETF | 27.47 | 1.75 | 6.81% | |
| INEQ | Columbia International Equity Income Etf | 39.41 | 5.22 | 15.26% | |
| LCIV | Logan Capital International ETF | 25.93 | 1.10 | 4.44% | |
| FFDI | Fidelity Fundamental Developed International ETF | 31.11 | 1.42 | 4.80% | |
| JINT | Janus Henderson International Core Alpha ETF | 25.16 | -0.00 | >-0.01% | |
| PRXI | Praxis Impact International ETF | 25.07 | 0.70 | 2.87% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.